0001062993-18-003490.txt : 20180817 0001062993-18-003490.hdr.sgml : 20180817 20180817194755 ACCESSION NUMBER: 0001062993-18-003490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180816 FILED AS OF DATE: 20180817 DATE AS OF CHANGE: 20180817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Thomas CENTRAL INDEX KEY: 0001355189 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 181026876 MAIL ADDRESS: STREET 1: 1764 BRIAR PLACE CITY: MERRICK STATE: NY ZIP: 11566 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2018-08-16 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001355189 Wegman Thomas C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 1 1 0 President Common Stock, $0.001 par value 2018-08-16 4 S 0 21092 51.2311 D 291327 D Common Stock, $0.001 par value 2018-08-17 4 S 0 2500 51.8912 D 947473 I See footnote The selling price of $51.2311 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $50.6155 to $52.02. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The selling price of $51.8912 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.8641 to $52.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares are held in trust on behalf of the reporting person and Ms. Toby Wegman. The reporting person is the co-trustee of the trust with Ms. Toby Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein. /s/ Thomas Wegman by Carl A. Valenstein, attorney- in-fact 2018-08-17